Back to today’s briefing

Story perspectives

AstraZeneca's CEO Warns Germany Risks Missing Drug Launches

4/21/2026

38 9 Full Breakdown

Summary

Story summary

AstraZeneca's CEO warned that Germany may miss new drug launches if it keeps limiting pharmaceutical spending.
He said proposed changes to the health insurance system could raise mandatory discounts on patented drugs.
The CEO called these regulations a dangerous backward step.
He noted United States pressure to lower drug costs has delayed European launches and risks turning Europe into a sales office rather than a hub for research and development.

1 of 1

Story summary

AstraZeneca's CEO warned that Germany may miss new drug launches if it keeps limiting pharmaceutical spending.
He said proposed changes to the health insurance system could raise mandatory discounts on patented drugs.
The CEO called these regulations a dangerous backward step.
He noted United States pressure to lower drug costs has delayed European launches and risks turning Europe into a sales office rather than a hub for research and development.